Related Experiment Video
Updated: May 14, 2026

07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondria in cancer stem cells: a target for therapy
Rute Loureiro1, Katia A Mesquita, Paulo J Oliveira
1CNC - Center for Neuroscience and Cell Biology, University of Coimbra. 3004-517 Coimbra, Portugal.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|January 31, 2013
Summary
Cancer stem cells (CSCs) drive tumor growth and recurrence. Targeting CSC mitochondria offers a promising strategy for developing novel cancer therapies and improving treatment outcomes.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer stem cells (CSCs) are crucial for tumor initiation, progression, recurrence, and treatment resistance.
- Mitochondria play a central role in cellular metabolism, energy production, and cell death pathways.
- Understanding CSC physiology, particularly mitochondrial functions, is vital for developing effective cancer treatments.
Purpose of the Study:
- To review recent discoveries and patents concerning mitochondrial bioenergetics and physiology in cancer stem cells.
- To highlight the importance of mitochondria as a therapeutic target within CSCs.
- To explore how understanding mitochondrial roles can lead to novel cancer treatment strategies.
Main Methods:
- Literature review focusing on recent patents and scientific discoveries.
- Analysis of research on cancer stem cell biology and mitochondrial function.
- Synthesis of information on CSC metabolism and bioenergetics.
Main Results:
- CSCs possess unique metabolic and bioenergetic profiles largely influenced by mitochondrial activity.
- Mitochondrial dysfunction and specific metabolic pathways are implicated in CSC survival and resistance to therapy.
- Recent patents indicate a growing interest in targeting CSC mitochondria.
Conclusions:
- Mitochondrial bioenergetics and physiology are critical determinants of cancer stem cell behavior.
- Targeting mitochondria in CSCs presents a significant opportunity for novel therapeutic interventions.
- Further research into CSC-mitochondria interactions is essential for eradicating cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

